Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- Check5 days agoChange DetectedThe sponsor name APR Applied Pharma Research s.a. and the Pathogenesis of COVID-19 from a cell biologic perspective section have been removed. The Helpful Links Provided by section is also deleted, reducing background context and source attribution on the study details page.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the ClinicalTrials.gov record. This does not modify the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's revision tag was updated to v3.6.2, replacing the previous v3.6.0. This reflects a newer revision of the page's documentation rather than a change to its substantive content.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now marks recruitment as closed with 'No longer looking for participants' and adds new user help sections (How to Read a Study Record, Common Questions, How to Join a Study); the 'Intervention / Treatment' label is reformatted to 'Intervention/Treatment' and the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page revision tag updated from v3.5.4 to v3.5.5, indicating a new version of the page. The visible study information remains unchanged.SummaryDifference0.0%

- Check62 days agoChange DetectedA new Revision: v3.5.4 was added, replacing the previous Revision: v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.